Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

Maladaptive coping mediates the influence of childhood trauma on depression and PTSD among pregnant women in South Africa.

Choi KW, Sikkema KJ, Velloza J, Marais A, Jose C, Stein DJ, Watt MH, Joska JA.

Arch Womens Ment Health. 2015 Jan 13. [Epub ahead of print]

PMID:
25578632
2.

Overdose Education and Naloxone Rescue Kits for Family Members of Individuals Who Use Opioids: Characteristics, Motivations, and Naloxone Use.

Bagley SM, Peterson J, Cheng DM, Jose C, Quinn E, O'Connor PG, Walley AY.

Subst Abus. 2015 Jan 7:1-6. [Epub ahead of print]

PMID:
25564892
3.

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients.

Podzamczer D, Rojas JF, Neves I, Ferrer E, Llibre JM, Leal M, Gorgolas M, Jose CM, Gatell JM, Abreu RC, Curto J, Domingo P, Pilar BM, Rozas N.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19773. doi: 10.7448/IAS.17.4.19773. eCollection 2014.

4.

Epigenetic dysregulation by nickel through repressive chromatin domain disruption.

Jose CC, Xu B, Jagannathan L, Trac C, Mallela RK, Hattori T, Lai D, Koide S, Schones DE, Cuddapah S.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14631-6. doi: 10.1073/pnas.1406923111. Epub 2014 Sep 22.

5.

The disappearing clip: an unusual complication in MRI biopsy.

Bourke AG, Peter P, Jose CL.

BMJ Case Rep. 2014 Aug 19;2014. pii: bcr2014204092. doi: 10.1136/bcr-2014-204092.

PMID:
25139917
6.

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.

Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A.

BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623.

PMID:
24894850
7.

The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART.

Foroudi F, Pham D, Rolfo A, Bressel M, Tang CI, Tan A, Turner S, Hruby G, Williams S, Hayne D, Lehman M, Skala M, Jose CC, Gogna K, Kron T.

Radiother Oncol. 2014 May;111(2):316-20. doi: 10.1016/j.radonc.2014.02.015. Epub 2014 Apr 17.

PMID:
24746580
8.

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

Dearnaley DP, Jovic G, Syndikus I, Khoo V, Cowan RA, Graham JD, Aird EG, Bottomley D, Huddart RA, Jose CC, Matthews JH, Millar JL, Murphy C, Russell JM, Scrase CD, Parmar MK, Sydes MR.

Lancet Oncol. 2014 Apr;15(4):464-73. doi: 10.1016/S1470-2045(14)70040-3. Epub 2014 Feb 26.

9.

Rheb regulates mitophagy induced by mitochondrial energetic status.

Melser S, Chatelain EH, Lavie J, Mahfouf W, Jose C, Obre E, Goorden S, Priault M, Elgersma Y, Rezvani HR, Rossignol R, Bénard G.

Cell Metab. 2013 May 7;17(5):719-30. doi: 10.1016/j.cmet.2013.03.014. Epub 2013 Apr 18.

10.

Recombinant Arthrobacter β-1, 3-glucanase as a potential effector molecule for paratransgenic control of Chagas disease.

Jose C, Klein N, Wyss S, Fieck A, Hurwitz I, Durvasula R.

Parasit Vectors. 2013 Mar 14;6:65. doi: 10.1186/1756-3305-6-65.

11.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

12.

Mitoplasticity: adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis.

Jose C, Melser S, Benard G, Rossignol R.

Antioxid Redox Signal. 2013 Mar 1;18(7):808-49. doi: 10.1089/ars.2011.4357. Epub 2012 Nov 27. Review.

PMID:
22989324
13.

Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies.

Jose C, Rossignol R.

Int J Biochem Cell Biol. 2013 Jan;45(1):123-9. doi: 10.1016/j.biocel.2012.07.005. Epub 2012 Jul 7. Review.

PMID:
22776740
14.

A novel human polycomb binding site acts as a functional polycomb response element in Drosophila.

Cuddapah S, Roh TY, Cui K, Jose CC, Fuller MT, Zhao K, Chen X.

PLoS One. 2012;7(5):e36365. doi: 10.1371/journal.pone.0036365. Epub 2012 May 3.

15.

Inhibition of Bothrops jararacussu venom activities by Plathymenia reticulata Benth extracts.

Nicole M F, Gleidy Aa S, Karine N C, Magali G S, José C C, Cháriston A Dal B, Márcio G Dos S, Francisco C G, Yoko OF.

J Venom Res. 2011;2:52-8. Epub 2011 Dec 28.

16.

Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10.

Hebert-Chatelain E, Jose C, Gutierrez Cortes N, Dupuy JW, Rocher C, Dachary-Prigent J, Letellier T.

Biochim Biophys Acta. 2012 May;1817(5):718-25. doi: 10.1016/j.bbabio.2012.01.014. Epub 2012 Feb 1.

17.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R, Gospodarowicz M, Sanders K, Kostashuk E, Swanson G, Barber J, Hiltz A, Parmar MK, Sathya J, Anderson J, Hayter C, Hetherington J, Sydes MR, Parulekar W; NCIC CTG PR.3/MRC UK PR07 investigators.

Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2.

18.

Male germ cells express abundant endogenous siRNAs.

Song R, Hennig GW, Wu Q, Jose C, Zheng H, Yan W.

Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13159-64. doi: 10.1073/pnas.1108567108. Epub 2011 Jul 25.

19.

AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation.

Jose C, Hébert-Chatelain E, Bellance N, Larendra A, Su M, Nouette-Gaulain K, Rossignol R.

Biochim Biophys Acta. 2011 Jun;1807(6):707-18.

20.

Antiproliferative activity of levobupivacaine and aminoimidazole carboxamide ribonucleotide on human cancer cells of variable bioenergetic profile.

Jose C, Bellance N, Chatelain EH, Benard G, Nouette-Gaulain K, Rossignol R.

Mitochondrion. 2012 Jan;12(1):100-9. doi: 10.1016/j.mito.2011.03.010. Epub 2011 Apr 5.

PMID:
21447405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk